» Articles » PMID: 35359869

Pocket2Drug: An Encoder-Decoder Deep Neural Network for the Target-Based Drug Design

Overview
Journal Front Pharmacol
Date 2022 Apr 1
PMID 35359869
Authors
Affiliations
Soon will be listed here.
Abstract

Computational modeling is an essential component of modern drug discovery. One of its most important applications is to select promising drug candidates for pharmacologically relevant target proteins. Because of continuing advances in structural biology, putative binding sites for small organic molecules are being discovered in numerous proteins linked to various diseases. These valuable data offer new opportunities to build efficient computational models predicting binding molecules for target sites through the application of data mining and machine learning. In particular, deep neural networks are powerful techniques capable of learning from complex data in order to make informed drug binding predictions. In this communication, we describe Pocket2Drug, a deep graph neural network model to predict binding molecules for a given a ligand binding site. This approach first learns the conditional probability distribution of small molecules from a large dataset of pocket structures with supervised training, followed by the sampling of drug candidates from the trained model. Comprehensive benchmarking simulations show that using Pocket2Drug significantly improves the chances of finding molecules binding to target pockets compared to traditional drug selection procedures. Specifically, known binders are generated for as many as 80.5% of targets present in the testing set consisting of dissimilar data from that used to train the deep graph neural network model. Overall, Pocket2Drug is a promising computational approach to inform the discovery of novel biopharmaceuticals.

Citing Articles

TopMT-GAN: a 3D topology-driven generative model for efficient and diverse structure-based ligand design.

Wang S, Lin T, Peng T, Xing E, Chen S, Kara L Chem Sci. 2025; 16(6):2796-2809.

PMID: 39810998 PMC: 11726321. DOI: 10.1039/d4sc05211k.


The changing scenario of drug discovery using AI to deep learning: Recent advancement, success stories, collaborations, and challenges.

Chakraborty C, Bhattacharya M, Lee S, Wen Z, Lo Y Mol Ther Nucleic Acids. 2024; 35(3):102295.

PMID: 39257717 PMC: 11386122. DOI: 10.1016/j.omtn.2024.102295.


Using the structural diversity of RNA: protein interfaces to selectively target RNA with small molecules in cells: methods and perspectives.

Li A, Bouhss A, Clement M, Bauvais C, Taylor J, Bollot G Front Mol Biosci. 2023; 10:1298441.

PMID: 38033386 PMC: 10687564. DOI: 10.3389/fmolb.2023.1298441.


Recent Deep Learning Applications to Structure-Based Drug Design.

Verburgt J, Jain A, Kihara D Methods Mol Biol. 2023; 2714:215-234.

PMID: 37676602 PMC: 10578466. DOI: 10.1007/978-1-0716-3441-7_13.


Artificial intelligence to guide precision anticancer therapy with multitargeted kinase inhibitors.

Singha M, Pu L, Stanfield B, Uche I, Rider P, Kousoulas K BMC Cancer. 2022; 22(1):1211.

PMID: 36434556 PMC: 9694576. DOI: 10.1186/s12885-022-10293-0.

References
1.
Xu J, Zhang Y . How significant is a protein structure similarity with TM-score = 0.5?. Bioinformatics. 2010; 26(7):889-95. PMC: 2913670. DOI: 10.1093/bioinformatics/btq066. View

2.
Brylinski M, Feinstein W . eFindSite: improved prediction of ligand binding sites in protein models using meta-threading, machine learning and auxiliary ligands. J Comput Aided Mol Des. 2013; 27(6):551-67. DOI: 10.1007/s10822-013-9663-5. View

3.
Mouchlis V, Afantitis A, Serra A, Fratello M, Papadiamantis A, Aidinis V . Advances in de Novo Drug Design: From Conventional to Machine Learning Methods. Int J Mol Sci. 2021; 22(4). PMC: 7915729. DOI: 10.3390/ijms22041676. View

4.
Berman H, Battistuz T, Bhat T, Bluhm W, Bourne P, Burkhardt K . The Protein Data Bank. Acta Crystallogr D Biol Crystallogr. 2002; 58(Pt 6 No 1):899-907. DOI: 10.1107/s0907444902003451. View

5.
Yu Q . The dynamic roles of angiopoietins in tumor angiogenesis. Future Oncol. 2006; 1(4):475-84. DOI: 10.2217/14796694.1.4.475. View